Katherine “Katie” Rubino

Skinny Labels, Big Stakes For Pharmaceuticals: The Supreme Court’s Hikma v. Amarin Decision

Key Patent Issues For Foreign Companies To Consider Before Entry Into The U.S. Market; Part II

Seven Reasons Why Third-Party Funders Decline To Fund Patent Cases

AI Is Transforming Life Sciences. The Oversight Structures Are Still Catching Up.

Key Patent Issues For Foreign Companies To Consider Before Entry Into The U.S. Market

Rail Yard Automation Patents Derailed At Delaware District Court

A Recipe For Invalidation: Food Delivery Comparison Patents Found Ineligible Under § 101